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Abstract. Ischemic injury was formed in laboratory rats by applying mechanical pressure  
(110 mm Hg) to the anterior eye chamber for 30 minutes. The experiment revealed that the 
recombinant erythropoietin (50 IU/kg) prevents the development of degenerative changes in 
retinal layers caused by ischemic injury. Intensity of the protective effect of erythropoietin on the 
retina of rats was assessed after 1 hour and 72 hours of reperfusion after pathology simulation. 
The observed protective effect of erythropoietin with the development of ischemia was confirmed 
by laser Doppler flowmetry, electroretinography and histomorphometry. Identification and use of 
pharmacological agents with the preconditioning effect may be a new approach in the correction 
and prevention of retinal ischemia, which is the leading element in the pathogenesis of a number 
of ophtalmic pathologies. The possibility of pharmacological preconditioning of ischemic lesions 
of the retina with erythropoietin is essential for the development of anti-ischemic agents for the 
. 
Keywords: retinal ischemia-reperfusion; pharmacological preconditioning; erythropoietin; ATP-
dependent potassium channels. 
 
Introduction. Currently, vasodilators, 
fibrinolytics, anticoagulants, angioprotectors, 
biogenic stimulants, vitamins, immunomodulators, 
antioxidants are used in the world practice for the 
treatment of ischemic and reperfusion injury of 
retina, including diabetic and hypertensive 
retinopathy [1, 2].  
Treatment with the above drugs is not always 
successful enough, that ensures the relevance of 
the problem of expanding the range of drugs for 
the treatment of ophtalmic diseases associated with 
ischemic conditions. The leading element in the 
pathogenesis of a number of fundus vascular 
diseases is retinal ischemia (RI). Therefore, a 
recombinant erythropoietin is the most promising 
for the study, in our view. This pharmacological 
agent has established itself in a previously 
conducted studies of the protective effect of 
pharmacological preconditioning conducted in 
models of ischemia-reperfusion injury of the brain, 
heart, hind limb, kidney, placenta, liver, and other 
organs and tissues [3-14].  
Main part: Objective of this study was to 
investigate the effcet of distant ischemic 
treatment and prevention of ischemic ophthalmic pathologies
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preconditioning (DIP) and pharmacological 
preconditioning of the erythropoietin on 
microcirculation level and histomorphometric 
changes in the retina upon modeling the ischemia-
reperfusion of the eye. 
Materials and methods. Experiments were 
conducted in 140 male and female mongrel rats 
weighing 225-275 g. Ischemia-reperfusion injury of 
retina was simulated under anesthesia (chloral hydrate, 
300 mg/kg of animal body weight, i.p.) by applying 
mechanical pressure (110 mm Hg) to the anterior eye 
chamber for 30 minutes. The absence of ocular blood 
flow confirmed the formation of ischemia.  
To study the protective properties of the DIP and 
pharmacological preconditioning with erythropoietin, 
we conducted 7 series of the experiment, with 10 
animals in each group: 1 – intact animals; 2 – 
ischemia-reperfusion of the retina (control); 3 – with 
DIP correction; 4 – correction with recombinant 
erythropoietin (EPO); 5 – control + glibenclamide 
(ATP-dependent potassium channels blocker); 6 – 
DIP + glibenclamide; and 7 - EPO + glibenclamide;  
DIP was performed through 10 min compression 
of the femoral artery by applying a tourniquet on the 
proximal third of the hip for 40 min prior to modeling 
of retinal ischemia, followed by a 30-minute 
reperfusion episode.  
To study the preconditioning effect, the 
recombinant erythropoietin (Epocrin, Federal State 
Unitary Enterprise “Institute of Pure Biochemicals”) 
was administered i.p. at a dose of 50 IU/kg, 30 
minutes before pathology simulation. 
Glibenclamide (“Maninil” (Berlin-Chemie AG) 
was administered at a dose of 5 mg/kg once, 60 min 
before ischemia simulation.  
The degree of the protective effect was 
evaluated by the change of the microcirculation level, 
electrophysiological changes in the electroretinogram 
(ERG) and histomorphometric changes in the retina 
of rats after 1 hour and 72 hours of reperfusion. For 
this purpose, the animals were fixed under anesthesia 
(chloral hydrate, 300 mg/kg of animal body weight, 
i.p.). The level of microcirculation in rat retina was 
measured by laser Doppler flowmeter Biopac-
systems 150 MR-150 and acicular sensor TSD-l44 
(USA). For this purpose, the anesthetized animals 
were fixed and microcirculation level in the retina 
was measured in 10 points around the sclera at a 
pitch of 1 mm. Microcirculation curve was recorded 
during 20 seconds in each point. The obtained 10 
values were averaged with further recording of the 
average in the protocol and its use as the level of 
retinal microcirculation in the particular animal. The 
obtained 10 values were averaged with further use of 
the mean value as the level of retinal microcirculation 
in the particular group of animals. 
The electroretinography principle is to register 
the potential of retinal cells in response to light. 
Assessment of retinal electrical activity was 
conducted with a- and b-wave amplitude of the 
electroretinogram. a-wave is a negative vawe 
reflecting the functional activity of photoreceptors, 
and b-wave is a positive wave reflecting the electrical 
activity of bipolar and Muller cells with the possible 
invovement of the horizontal and amacrine cells. The 
evoked biopotentials were run at a frequency of  
1-1000 Hz, amplified, averaged and presented 
graphically on the screen using the Biopac-systems 
MP-150 with a computer program AcqKnowledge 
4.2 (USA). ERG recording was carried out for 0.5 
seconds in each rat in groups. To assess the severity 
of retinal ischemia, b- and a-wave amplitude ratio - 
b/a ERG index - is widely used (Neroyev V.V. et al., 
2004). The 10 values obtained in each series were 
averaged with further recording in the protocol [5]. 
Then, the eyeball was subjected to enucleation. 
For histological examination, the eye and its 
immediately adjacent tissues were fixed in 10% 
formalin solution. After fixation, the material was 
completely embedded in paraffin under standard 
conditions. The pieces were orientated in the blocks 
so as to receive upon sectioning the preparations in 
the meridian direction strictly through the center of 
the eyeball. Sections for standard histological 
examination were stained with hematoxylin and 
eosin. A descriptive study of histological preparations 
was performed with the microscope Axio Scope A1 
(Carl Zeiss Microimaging GMbH, Germany). 
Morphometry of retinal layers was performed with 
the program ImageJ 1.47 [11]. 
The significance of changes in absolute 
parameters was determined by the difference method 
of variation statistics with finding the average values 
of the shifts, the arithmetic mean, and the probability 
of possible error (p) by using the Student tables. 
Differences were considered significant at p<0.05. 
Results and discussion. Hemodynamic 
impairments in retinal blood flow system after 1 h and 
72 h of reperfusion after pathology simulation led to the 
electrophysiological and morphological changes in the 
retina, typical of ischemia, which confirmed the 
adequacy of the chosen pathology model.  
After pathology simulation, the 
microcirculation level of the retina was measured 
after 1 h and 72 h of reperfusion by LDF method. 
The obtained results are shown in Table 1. 
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The level of microcirculation in the retina of 
intact rats was 738.9 ± 37.6 pu (perfusion units). 
The level of microcirculation after ischemia 
simulations in the control group reached  
1155.0 ± 51.9 pu after 1 h of reperfusion, which 
was significantly higher than the value in the group 
of intact animals (p<0.001). Upon DIP correction, 
the level of microcirculation in the retina after 1 h 
of reperfusion decreases significantly up to 
952.0±25.8 pu (р<0.05) as compared to the control 
group (with RI).   
Table 1 
Changes in the microcirculation level of the retina after 
1 h and 72 h of reperfusion (M±m; n=10) 
 
No
. 
Experimental 
groups 
Microcirculatio
n level after 1 h, 
pu 
Microcirculatio
n level after  
72 h, pu 
1. Intact  738.9±37.6у 743.9±5.0 у 
2. Retinal 
ischemia (RI) 
1155.0±51.9* 353.3±11.7* 
3. RI+DIP 952.0±25.8*у 638.5±15.8*у 
4. RI+EPO 50 
IU/kg  
798.5±12.3 у 724.0±4.1 у 
5. RI + 
glibenclamide
, 5 mg/kg  
1135.8±31.2* 359.4±10.3* 
6. RI + DIP + 
glibenclamide
, 5 mg/kg  
1144.7±20.7* 361.7±13.9* 
7. RI + EPO 50 
IU/kg + glib., 
5 mg/kg 
1148.5±14.3* 372.3±13.4* 
 
Note: *- at p<0.05 as compared to intact animals; 
y
- 
at p<0.05 as compared to control animals 
 
Upon correction of the simulated EPO 
pathology, the microcirculation level in the group 
decreases up to 798.5 ± 12.3 pu and also significantly 
differs from the values   in the control group 
(p<0.001). Administration of glibenclamide, an ATP-
sensitive potassium channels blocker, in the groups 
with DIP and EPO correction prevented the reduction 
of microcirculation level, which confirms the 
presence of the preconditioning effect in the 
recombinant EPO at a dose of 50 IU/kg in the model 
of retinal ischemia of rats after 1 hour of reperfusion. 
The results of evaluation of microcirculation 
level in rat retina after 72 hours of reperfusion after 
RI and its DIP and EPO correction at a dose of 50 
IUkg are presented in Table 1. 
The level of microcirculation in the retina of intact 
rats was 743.9±5.0 pu. The level of microcirculation 
after ischemia simulations in the control group reached 
353.3±11.7 pu after 72 h of reperfusion, which was 
significantly lower than the value in the group of intact 
animals (p<0.001), which indicates the formation of 
ischemia by 72 h of reperfusion. Upon DIP correction, 
the level of microcirculation in the retina after 72 h of 
reperfusion increases significantly up to 638.5±15.8 pu 
(р<0.05) as compared to the control group (Table 1).  
Upon correction of the simulated EPO 
pathology, the microcirculation level in the group 
increases up to 724.0 ± 4.1 pu, which significantly 
differs from the values in the control group (p<0.001) 
and tends to the value in the group of intact animals. 
Administration of glibenclamide in the groups 
with DIP and EPO correction prevented the increase 
in microcirculation level, which confirms the 
presence of the preconditioning effect in the 
recombinant EPO at a dose of 50 IU/kg in the model 
of retinal ischemia of rats after 72 hour of 
reperfusion. 
After simulating ischemia and measuring the 
level of the microcirculation in the retina, the retinal 
electrophysiological state caused by the evoked 
potential was assessed. The data obtained after 1 h 
and 72 h of reperfusion are shown in Table 2. 
Table 2 
Evaluation results of electrophysiological condition  
of the retina after 1 h and 72 h of reperfusion  
(М±m; n=10) 
 
No. Experimental groups after 1 
hour 
b/a, ru, 
after 72 
hours 
1. Intact  2.6±0.09у 2.5±0.10у 
2. Control 2.0±0.09* 1.2±0.04* 
3. DIP correction 2.3±0.07*у 2.0±0.08у 
4. EPO correction, 50 IU/kg 2.5±0.07у 2.3±0.06у 
5. Control + glibenclamide, 
5 mg/kg 
2.2±0.06* 1.2±0.05* 
6. DIP correction + 
glibenclamide, 5 mg/kg 
2.1±0.08* 1.2±0.04* 
7. EPO correction, 50 IU/kg 
+ glibenclamide,  
5 mg/kg 
2.2±0.09* 1.2±0.06* 
 
Note: *– at p<0.05 as compared to intact animals; y – 
at p<0.05 as compared to control animals 
 
The b/a index in the control group was 2.0 ± 
0.09 ru, which significantly differs from the values in 
the group of intact rats. Increase of this indicator in 
the groups with the correction with recombinant EPO 
up to 2.5 ± 0.07 ru and DIP - up to 2.3 ± 0.07 ru 
indicates the preservation of retinal 
electrophysiological function after pathology 
simulation. Administration of glibenclamide in the 
groups of animals with EPO and DIP correction led 
b/a, ru, 
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to a decrease in the b/a index up to values   
significantly different from those of the intact group, 
which indicates the blockade of the ATP-dependent 
potassium channel and confirms the presence of 
preconditioning properties of EPO at a dose of 50 
IU/kg and DIP in the RI model after 1 h and 72 h of 
reperfusion. 
ERG after 72 h of reperfusion was performed 
after measuring the level of retinal microcirculation 
in experimental animals. The results from these 
experiments are shown in Table 2. 
The b/a index in the control group was 1.2±0.04 
ru, which statistically significantly differs from the 
values in the group of intact rats. Increase of this 
indicator in the groups with the correction with 
recombinant EPO up to 2.3 ± 0.06 ru and DIP - up to 
2.0 ± 0.08 ru indicates the  preservation of retinal 
electrophysiological function after pathology 
simulation. Administration of glibenclamide in the 
groups of animals with EPO and DIP correction led 
to a decrease in the b/a index up to values   
significantly different from those of the intact group, 
which indicates the blockade of the ATP-dependent 
potassium channel and confirms the presence of 
preconditioning properties of EPO at a dose of 50 
IU/kg and DIP in the RI model after 72 h of 
reperfusion. 
Reduction of the b/a index in animals with 
simulated ischemia (control) was caused by 
inhibition of the positive ERG b-wave, which 
indicates an impaired electrophysiological function of 
bipolar and Muller cells with the possible 
involvement of the horizontal and amacrine cells. 
Preservation of the electrophysiological function of 
the photoreceptor layer is confirmed by the absence 
of adverse changes in the negative a-wave. 
Morphological and morphometric studies 
confirmed the electrophysiological changes in the 
retina. The inner nuclear and photoreceptor layers 
were subjected to the morphometric assessment. The 
retina of the animals with EPO and DIP correction 
showed the preservation of the structure of inner 
nuclear, outer reticular, and the outer nuclear layers. 
The control group shows rarefication of the outer 
reticular layer and the separation of the photoreceptor 
layer from the pigment epithelium. During 
administration of glibenclamide, no protective effect 
of DIP and EPO was observed, the morphological 
pattern of the retinal layers in these groups did not 
significantly differ from the control group. 
The results from this experiment are shown in 
Table 3. 
Table 3 
Morphometric indices of the retinal layers  
in experimental animals  
(M±m; n=10) 
 
N
o. 
Experim
ental 
groups 
1 h of reperfusion 
72 h of 
reperfusion 
Inner 
nuclear 
layer 
Photorece
ptor layer 
Inner 
nuclear 
layer 
Photore
ceptor 
layer 
1. Intact 23.5±0.8
y
 38.4±0.8 23.8±1.0
у
 38.1±1.2 
2. RI 25.9±0.6* 39.1±0.7 20.3±0.8* 36.9±0.9 
3. DIP 24.0±0.5
y
 38.4±0.9 21.7±0.4*
у
 37.8±0.8 
4. EPO 23.8±0.6
y 
38.3±0.9 23.3±0.7
у
 38.0±1.0 
5. 
Control 
+ glib. 
26.0±0.7* 39.1±0.6 20.5±0.4* 37.1±0.8 
6. 
DIP + 
glib. 
25.8±0.6* 39.2±0.6 20.6±0.6* 36.9±0.8 
7. 
EPO + 
glib. 
25.7±0.6* 39.0±0.5 20.3±0.5* 37.0±0.9 
 
Note: *– at p<0.05 as compared to intact animals; y – 
at p<0.05 as compared to control animals 
 
 
During morphometric analysis it should be noted 
that no reliable changes in thickness of the 
photoreceptor layer in experimental groups is 
observed in any of the series, that confirms the 
absence of changes in the negative ERG a-wave. 
The inner nuclear layer was the most sensitive to 
the effect of ischemia-reperfusion. Increase in 
thickness of the layer after 1 h of reperfusion is 
caused by edema, and its thinning after 72 hours is 
due to degenerative processes in the retina. 
The group of animals treated with EPO had the 
inner nuclear layer thickness after 1 h and 72 h of 
reperfusion equal to 23.8 ± 0.62 μm and 23.7 ± 0.71 
μm, respectively, which significantly differs from the 
values in group with the RI. 
The group of animals treated with DIP had the 
inner nuclear layer thickness after 1 h and 72 h of 
reperfusion equal to 24.0±0.53 μm and 23.6±0.52 
μm, respectively, which significantly differs from the 
values in the control group. 
Pretreatment with glibenclamide contributed to 
the elimination of protective actions of both DIP and 
EPO, which confirms the presence of anti-ischemic 
effect in the model of retinal ischemia in rats with 
DIP and EPO at a dose of 50 IU/kg by virtue of the 
preconditioning effect.  
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Conclusion: 
Based on these findings, we can conclude that 
the correction of ischemic injuries of the retina in 
laboratory rats is achieved by the preconditioning 
effect of DIP and recombinant EPO at a dose of  
50 IU/kg of animal body weight, which is confirmed 
by LDF and ERG methods, and by the results of 
morphological and morphometric studies. 
The absence of protective effect in groups 
treated with EPO and glibenclamide, and DIP and 
glibenclamide indicates that the retinoprotection is 
due to the preconditioning effect, the key role in 
which is played by the ATP-dependent potassium 
channels. 
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